The 18 important medicines that Australians are missing out on
Eighteen innovative medicines for cancer, mental illness and rare diseases approved overseas are unavailable in Australia, Medicines Australia warned. The lobby group says the complex approval process and low government reimbursement rates make the local market unattractive to pharmaceutical companies. Patients like Tina Powney, who needs a new IPAH treatment costing sixteen thousand dollars, cannot access these life-changing therapies.
Take it further — get the full app and never miss a moment of what's happening in Australia.
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
Published 19 Jul 2026, 19:00 UTC · Updated 19 Jul 2026, 19:11 UTC
Summary by OZbrief Editorial. Original report: SMH. Editorial policy · Corrections